‼️Well,it finally happened! I’m thrilled about Matching into my dream speciality, GI & Hepatology @UBuffalo_GI 💩 🦬
This would not have been possible without support from my mentors, family, and fiancé @NazaninI6 🤩
@AmCollegeGastro#GITwitter@AmerGastroAssn
🚨 URGENT
Iran’s women’s national football players are in immediate danger.
While competing in Australia, several players refused to sing the Islamic Republic’s regime anthem. In response, a host on Iran’s state television (IRIB) publicly declared that refusing the anthem during wartime is treason and said traitors deserve the harshest punishment.
In Iran, this is not rhetoric.
When state media labels someone a traitor, it often becomes a signal for security forces to arrest, torture, or execute them.
Footage also shows players signaling “HELP” in sign language from their team bus as they were leaving the stadium. Iranians in Australia ran after the bus trying to stop it, desperate to protect them.
If these athletes are forced back to Iran, their lives will be at risk.
The world must act before it is too late.
@FootballAUS@AlboMP@dfat@AusHumanRights@FIFAcom@FIFPRO@UNHumanRights@amnesty@hrw@Reuters@BBCWorld@guardian@SkyNews
#IranRevolution2026
#IranMassacre
#DigitalBlackoutIran
#RezaPahlaviForIran
#KingRezaPahlavi
🚨Are you UNMATCHED to #GIFellowship?🫵
It’s the worst…but you’re not the only one 😞
You’ve got to pick yourself up and strategize for the months ahead 💪🏻
👀 Watch this video and refer to the links below for 🔑 advice and next steps 👇🏻👇🏻👇🏻
📊GI Fellowship and 4th Year Programs List
https://t.co/Ai7sjPygVc
📝Becoming a Competitive GI Applicant
https://t.co/fQJQ7DjRok
📝Paving a Path After an Unsuccessful Match
https://t.co/psVQxLZR1U
🔊Gut Talk Podcast
https://t.co/RCSPZSu1AQ
🎙️Training Committee Interview (Video #6)
https://t.co/Ai7sjPygVc
#GITwitter #FellowshipMatch @TheNRMP@Inside_TheMatch
🚨 Applying to the GI #FellowshipMatch? 🫵
⏳ Make sure you get your rank list finalised and submitted ✅
🗓️ Deadline: November 19th ‼️
Having trouble ranking? 😫
👀 Watch below for some 🔑 tips and links to prime advice from 🔥 GI faculty 👇🏻👇🏻👇🏻
📜@JosephHabibi_MD ➡️ https://t.co/IdKGKM4FTp
📜@doctornikkid ➡️ https://t.co/NDYPyOSsY5
🌟 Hot Off the Press ‼️
🦠 Does HIV affect IBD pathogenesis? 🤔
It very well might…
Check out our newly published 📝 for a more in-depth analysis and food for thought ⬇️
Grateful to all our coauthors and mentors 🙏🏻
📜 https://t.co/GcnJVvhjsl
📕 @WileyGlobal#GITwitter #FutureOfGI
The famous "Table 7" from the Gupta et al. paper on surveillance of colon polyps. A paper I refer to regularly in my practice and when teaching fellows. A must-read for all GI trainees. #Medtwitter#GITwitter@AGA_Gastro@cwruim@CWRU_GI
https://t.co/IRXUZCZ3sn
‼️Well,it finally happened! I’m thrilled about Matching into my dream speciality, GI & Hepatology @UBuffalo_GI 💩 🦬
This would not have been possible without support from my mentors, family, and fiancé @NazaninI6 🤩
@AmCollegeGastro#GITwitter@AmerGastroAssn
Hepatic Hydrothorax & Spontaneous Bacterial Empyema
▪️HH & SBE ➡️ poor prognosis
▪️No MELD exception points for HH/SBE
▪️HH often RIGHT-sided!
▪️HH Dx when serum:pleural albumin>1.1
▪️AVOID chest tube/pleurodesis for HH
▪️SBE when (+) Cx and >250 PMNs
🔗 https://t.co/arSxV7UMkd
With routine care, half of patients with compensated MASH cirrhosis & obesity develop major adverse outcomes (MALO—such as liver failure, cancer, transplant, death) in 15 yrs.
Bariatric surgery favorably alters this trajectory, reducing that risk by 72%.
https://t.co/1vUWwCMH71
Hello TL;DR-IBD Followers!
Here is my latest video breaking down the QUASAR Study evaluating the efficacy of the IL-23 Inhibitor Guselkumab (TREMFYA) in Ulcerative Colitis!
Do IL-23s have a place in UC?
Should we use them First Line?
Are there differences between the IL-23s?
Watch, see if you agree, and comment!
What a great episode! Thank you Dr. @laura_tee_mdgi for creating @TLDR_IBD ! This is going to be extremely helpful for all in training and interested in IBD. Looking forward to more episodes 🙏🏻
@UBuffalo_GI@CrohnsColitisFn#GITwitter
Welcome to TL;DR IBD (or Too Long, Didn't Read IBD), where I post succinct capsule summaries of the latest papers in IBD in 4 minutes, or less
In the first episode, I summarize the EXIT trial, which sought to evaluate whether withdrawal of Anti-TNF therapy is a reasonable option for IBD patients in long-term clinical remission
Please follow this account and share with your colleagues if you enjoyed this content
Link to the article in the comments